AbCellera Biologics
ABCL
ABCL
146 hedge funds and large institutions have $334M invested in AbCellera Biologics in 2024 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.03% more ownership
Funds ownership: 35.53% → 38.56% (+3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less call options, than puts
Call options by funds: $973K | Put options by funds: $1.3M
Holders
146
Holding in Top 10
1
Calls
$973K
Puts
$1.3M
Top Buyers
| 1 | +$23.2M | |
| 2 | +$5.72M | |
| 3 | +$2.14M | |
| 4 |
Two Sigma Investments
New York
|
+$2.12M |
| 5 |
Two Sigma Advisers
New York
|
+$1.26M |
Top Sellers
| 1 | -$5.07M | |
| 2 | -$4M | |
| 3 | -$2.64M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$1.93M |
| 5 |
Renaissance Technologies
New York
|
-$1.35M |